GSE115602
Enhancer Release and Retargeting” Activates Disease Susceptibility Genes (ChIP-Seq)
We used genome wide ChIP-seq to examine the chromatin histone changes after the knockdown of one of cohesin subunit, RAD21, in MCF7 breast cancer cells. Overall design: Examination of h3k4me1,h3k4me3 histone modifications by ChIP-seq.